The ISO Certification is an important milestone on OncoSil's commercialization pathway. The company now plans to secure the CE Mark in both pancreatic and liver cancer indications in the September quarter, 2015.
News: OncoSil Medical achieves major milestone in CE Marking Pathway
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
-0.020(1.80%) |
Mkt cap ! $20.51M | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $19.98K | 18.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3196 | $1.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 3598 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| OSL (ASX) Chart |